Andrea Sloan pleads with BioMarin CEO

Andrea_Sloan_continues_to_fight_for_drug_1497410000_3123194_ver1.0_640_480

AUSTIN (KXAN) - An Austin woman locked in a bitter battle for her life reached out to the CEO of a drug company, pleading for the business to change their minds.

KXAN Investigates has been following Andrea Sloan’s story for about a month as she fights for an experimental cancer drug her doctors say is her best hope for survival.

The drug company BioMarin has refused to grant her “compassionate use” of the drug which is not yet approved by the FDA.

On Wednesday, she made a direct plea to the CEO of the drug company.

“I do have to tell you that I’m a little frustrated at our inability to have an open dialogue about how we might be able to get to a solution,” Sloan said, “that both advances your goals of making sure that this treatment available to everyone and advances my goal of saving my life.”

Sloan has been fighting ovarian cancer for seven years and her doctors say her body can no longer tolerate traditional treatments.

The drug company says they can’t guarantee the safety or effectiveness of the drug and that it should be available to all patients equally. But compassionate use allows drug companies to make an exception for patients like Sloan, who have no other options.

blog comments powered by Disqus